BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8309847)

  • 1. Estramustine potentiates the effects of irradiation on the Dunning (R3327) rat prostatic adenocarcinoma.
    Widmark A; Damber JE; Bergh A; Henriksson R
    Prostate; 1994; 24(2):79-83. PubMed ID: 8309847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potentiation of focal ultrasound treatment of prostate adenocarcinoma by concomitant chemotherapy with estramustine phosphate and paclitaxel].
    Paparel P; Chapelon JY; Curiel L; Rabilloud M; Chesnais S; Gelet A
    Prog Urol; 2004 Feb; 14(1):40-6. PubMed ID: 15098750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of tumour cells, stroma and apoptosis in rat prostatic adenocarcinoma following treatment with histamine, interleukin-2 and irradiation.
    Johansson S; Landström M; Henriksson R
    Anticancer Res; 1999; 19(3A):1961-9. PubMed ID: 10470141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biological studies of estramustine phosphate as a novel radiation sensitizer.
    Kim JH; Khil MS; Kim SH; Ryu S; Gabel M
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):555-7. PubMed ID: 8005815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 6-methylene progesterone on growth, morphology, and blood flow of the Dunning R3327 prostatic adenocarcinoma.
    Damber JE; Bergh A; Daehlin L; Petrow V; Landström M
    Prostate; 1992; 20(3):187-97. PubMed ID: 1574466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to prostatic cancer chemotherapy using the Dunning R3327H prostatic adenocarcinoma.
    Padilla GM; Petrow V; Marts SA; Mukherji S
    Prostate; 1985; 6(2):129-43. PubMed ID: 3975175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood flow in the Dunning R3327H rat prostatic adenocarcinoma; effects of oestradiol and testosterone.
    Daehlin L; Damber JE
    Urol Res; 1986; 14(2):113-7. PubMed ID: 3727214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
    Sylvester PW; Ip MM
    Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the effects of oestrogen in the male. Some effects of different oestrogenic substances in rats and men with prostatic carcinoma.
    Daehlin L
    Scand J Urol Nephrol Suppl; 1985; 91():1-44. PubMed ID: 3868029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response of Dunning R3327 prostatic adenocarcinoma to IL-2, histamine and radiation.
    Johansson S; Landström M; Hellstrand K; Henriksson R
    Br J Cancer; 1998 Apr; 77(8):1213-9. PubMed ID: 9579825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the preestrogen 4-androstene-3,17-dion-19-al on the Dunning R3327 prostatic adenocarcinoma.
    Marks TA; Petrow V
    Cancer Res; 1983 Aug; 43(8):3687-90. PubMed ID: 6861138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma.
    Zaccheo T; Giudici D; di Salle E
    Prostate; 1997 Feb; 30(2):85-91. PubMed ID: 9051146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour.
    Granfors T; Tomic R; Bergh A; Rydh M; Löfroth PO; Widmark A
    Urol Res; 1999 Oct; 27(5):357-61. PubMed ID: 10550524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of prostate cancer growth by estramustine and etoposide: evidence for interaction at the nuclear matrix.
    Pienta KJ; Lehr JE
    J Urol; 1993 Jun; 149(6):1622-5. PubMed ID: 8501820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A; Tomic R; Carlsson-Bostedt L; Stigbrand T
    Prostate; 1988; 12(4):287-98. PubMed ID: 3393491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II evaluation of docetaxel plus one-day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma.
    Sinibaldi VJ; Carducci MA; Moore-Cooper S; Laufer M; Zahurak M; Eisenberger MA
    Cancer; 2002 Mar; 94(5):1457-65. PubMed ID: 11920502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiosurgery of the rat dunning R3327-AT1 prostate tumor.
    Henke K; Hartmann GH; Peschke P; Hahn EW
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):385-91. PubMed ID: 8892464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma.
    Granfors T; Damber JE; Bergh A; Landström M; Löfroth PO; Widmark A
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1031-6. PubMed ID: 9392541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated radiotherapy of rat prostatic adenocarcinoma (Dunning R3327-PAP) in nonanesthetized animals.
    Granfors T; Bergh A; Löfroth PO; Widmark A
    Prostate; 1999 Apr; 39(1):16-22. PubMed ID: 10221261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clonidine-induced hypotension and dopamine-induced hypertension on blood flows in prostatic adenocarcinoma (Dunning R3327) and normal tissues.
    Jonsson O; Widmark A; Grankvist K; Damber JE; Henriksson R
    Prostate; 1992; 20(3):225-32. PubMed ID: 1574468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.